Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_assertion type Assertion NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_head.
- NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_assertion description "[Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_provenance.
- NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_assertion evidence source_evidence_literature NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_provenance.
- NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_assertion SIO_000772 23396606 NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_provenance.
- NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_assertion wasDerivedFrom befree-20140225 NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_provenance.
- NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_assertion wasGeneratedBy ECO_0000203 NP360248.RArGRtqKhE8SVSiRfvX022RAfU-I6AXHPWEWovWWA4Lrg130_provenance.